Free Trial

Grifols: S-RAAS Deal With Haier Now At Regulatory Approval Stage

HEALTHCARE

Grifols (GRF SM) headline:


  • GRIFOLS SAYS HAIER DEAL NOW SUBJECT TO REGULATORY APPROVAL
  • Mgmt did indicate due diligence was complete as of yesterday (29-Feb) so it could have been assumed regulatory approval and final closure would be next steps.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.